Latest News & Updates

Breaking News

14 hours ago
Simantini Singh Deo

DIMERx Appoints Former FDA Division Director Dr. Lee S. Simon As Chief Advisor For Clinical Development And Regulatory Strategy

Actithera Appoints Dr. Darshan Dalal As CMO To Lead Clinical Strategy And Advance FAP-Targeting Radioligand Therapy Into Trials

Vaibhavi M.

BioCardia Appoints Marvin Slosman To Its Board, Thanking Dr. Richard Krasno For Nearly A Decade Of Service

Simantini Singh Deo

Apellis Reports Robust Clinical Outcomes For EMPAVELI In Rare Kidney Diseases Following NEJM Publication

Vaibhavi M.

Sapu Nano Reports Major Reduction In GI Drug Exposure With IV Sapu003, Highlighting Strong PK And Tissue-Distribution Benefits; Supports Enhanced Tolerability and Antitumor Activity

Vaibhavi M.

Other trending news you may like to read

DIMERx Appoints Former FDA Division Director Dr. Lee S. Simon As Chief Advisor For Clinical Development And Regulatory Strategy

DIMERx appoints former FDA division director Dr. Lee Simon to guide clinical and regulatory strategy, advancing its non-addictive pain candidate DMX-101.

Simantini Singh Deo

Actithera Appoints Dr. Darshan Dalal As CMO To Lead Clinical Strategy And Advance FAP-Targeting Radioligand Therapy Into Trials

Actithera appoints Dr. Darshan Dalal as CMO to advance its FAP-targeting radioligand therapy and expand its precision radiopharmaceutical pipeline.

Vaibhavi M.

BioCardia Appoints Marvin Slosman To Its Board, Thanking Dr. Richard Krasno For Nearly A Decade Of Service

BioCardia appoints Marvin Slosman to its Board as Richard Krasno retires, strengthening leadership for its cardiovascular cell therapy portfolio.

Simantini Singh Deo

Apellis Reports Robust Clinical Outcomes For EMPAVELI In Rare Kidney Diseases Following NEJM Publication

NEJM publishes Phase 3 VALIANT data showing EMPAVELI delivers major proteinuria reduction and kidney function benefits in C3G and IC-MPGN.

Vaibhavi M.